Special Drug Use-results Survey for Long-term Use of Fostamatinib in Chronic Idiopathic Thrombocytopenic Purpura

What this Trial Is About

This research aims to evaluate the safety and effectiveness of taking fostamatinib over a long period in Japanese patients who have chronic idiopathic thrombocytopenic purpura, a condition affecting platelet counts. The study focuses on how the drug performs in real-world use conditions among this patient group. Participants will receive fostamatinib by mouth as their treatment. The study involves monitoring patients during their ongoing treatment with fostamatinib, without a comparison group or alternative treatment. There are no additional interventions or device uses described. Throughout the study, researchers will observe and record any adverse events that occur over an 18-month period to assess the safety of long-term fostamatinib use. The study duration and participant involvement focus on this safety monitoring and evaluation of treatment effects during normal clinical use.

Special Drug Use-results Survey for Long-term Use (Fostamatinib)